The World Economic Forum’s white paper Intelligent Clinical Trials: Using Generative AI to Fast-Track Therapeutic Innovations (2024) shows how GenAI can address inefficiencies that delay therapies. Traditional trials take 8–12 years, cost $2.5 billion, and face 90% failure rates. GenAI can optimize design, site selection, recruitment, data analysis, and regulatory submissions. Case studies from Moderna, Amgen, and Insilico Medicine demonstrate reduced time and cost. Barriers include fragmented data, inconsistent standards, regulation, skills gaps, and trust. The report calls for shared data infrastructure, adaptive policies, and public-private collaboration to accelerate safe, effective deployment.

Join for free to read